Potentiation of Trauma Exposure in Post-traumatic Stress Disorder by Repeated Transcranial Magnetic Stimulation (TETT-STIM)

July 8, 2020 updated by: University Hospital, Tours

Potentiation of Trauma Exposure in Post-traumatic Stress Disorder by Repeated Transcranial Magnetic Stimulation : A Control Randomized Study

The aim of this study is to assess the efficacy in PTSD treatment of concomitant voluntary reactivation of personal traumatic memories with neuromodulation of the right dorsolateral prefrontal cortex using 10Hz rTMS, compared to 1Hz rTMS, during 2 weeks.

Study Overview

Detailed Description

Post-Traumatic Stress Disorder (PTSD) is characterized by intrusive and persistent memory of past result from an event causing or able to cause death, be a threat of death, a severe injury or constitute a threat for physical integrity. It is a frequent disorder in general population (8%). In France, The most frequent traumatic events causing PTSD are serious accidents, rape, physical assaults, violence, etc. PTSD treatment involves antidepressant and cognitive and behavioural psychotherapy, which encourage exposure to elements that remind the trauma (memories, circumstances), with the objective of reducing the fear associated with the traumatic memories. Innovative therapeutic strategies aim to improve the psychotherapeutic effect with enhancement drugs or using neuromodulatory techniques, such as repeated transcranial magnetic stimulation (rTMS).

The aim of this study is to assess the efficacy in PTSD treatment of concomitant voluntary reactivation of personal traumatic memories with neuromodulation of the right dorsolateral prefrontal cortex using 10Hz rTMS, compared to 1Hz rTMS, during 2 weeks.

Study Type

Interventional

Enrollment (Actual)

39

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • PCLS score >40
  • Able to give his written informed consent
  • Not participating another study
  • Affiliation to a social security system
  • Having a PTSD for 3 months
  • No treatment modification for 4 weeks (Psychotropic treatment or structured psychotherapy)

Exclusion Criteria:

  • Partially deaf with equipment
  • people with identified neurological disease
  • people with addiction to psychoactive substance
  • people who can't conform to tests
  • people having a contraindication for rTMS (cochlear implant )
  • people suffering from chronicle or acute delusional disorder
  • any circumstances making the people unable to understood nature, aim or consequences of the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: rTMS 1Hz
Subjects have 8 session of trauma exposure with repeated transcranial magnetic stimulation (rTMS) at 1Hz on dorsolateral prefrontal cortex (1Hz rTMS is describe in the literature to have no effect on the dorsolateral prefrontal cortex). psychoneurological assessment. Electrodermal conductance measure With conductivity meter . Heart rate measure With electrocardiogram
trauma exposure + repeated transcranial magnetic stimulation at 1Hz
psychoneurological assessment
electrodermal conductance measure
heart rate measure
Experimental: rTMS 10Hz
Subjects have 8 session of trauma exposure with repeated transcranial magnetic stimulation (rTMS) at 10Hz on dorsolateral prefrontal cortex (10Hz rTMS is describe in the literature to have effect on the dorsolateral prefrontal cortex). psychoneurological assessment. Electrodermal conductance measure With conductivity meter. Heart rate measure with electrocardiogram
psychoneurological assessment
electrodermal conductance measure
heart rate measure
trauma exposure + repeated transcranial magnetic stimulation at 10Hz

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline Score at Clinician administered PTSD scale
Time Frame: inclusion ; 1 months; 3 months
Score at Clinician administered PTSD scale
inclusion ; 1 months; 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline Score at PTSD Checklist (self-assessment)
Time Frame: inclusion ; 1 month; 3 months
Score at PTSD Checklist (self-assessment) for severity of PTSD
inclusion ; 1 month; 3 months
Change from baseline Score at PTSD Checklist (self-assessment) for different dimensions of PTSD
Time Frame: inclusion ; 1 month; 3 months
Score at PTSD Checklist (self-assessment) for severity of different dimensions of PTSD
inclusion ; 1 month; 3 months
Change from baseline Score at anxiety and depression item on Hamilton Anxiety Rating Scale (HAM-A)
Time Frame: inclusion ; 1 month; 3 months
Score at anxiety and depression item on Hamilton Anxiety Rating Scale (HAM-A)
inclusion ; 1 month; 3 months
Change from baseline Score at depression item on Hamilton Anxiety Rating Scale (HAM-A)
Time Frame: inclusion ; 1 month; 3 months
Score at depression item on Hamilton Depression Rating Scale (HAM-D)
inclusion ; 1 month; 3 months
Change from baseline heart rate
Time Frame: inclusion ; 1day ; 1 month, 3 months
heart rate
inclusion ; 1day ; 1 month, 3 months
Change from baseline electrodermal conductance
Time Frame: inclusion ; 1day ; 1 month, 3 months
electrodermal conductance measure
inclusion ; 1day ; 1 month, 3 months
Adverse effect
Time Frame: inclusion ; 1day ; 1 month, 3 months
Adverse effect
inclusion ; 1day ; 1 month, 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Wissam EL-HAGE, PhD, Chru Tours

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 4, 2016

Primary Completion (Actual)

April 17, 2020

Study Completion (Actual)

April 17, 2020

Study Registration Dates

First Submitted

October 14, 2015

First Submitted That Met QC Criteria

October 22, 2015

First Posted (Estimate)

October 23, 2015

Study Record Updates

Last Update Posted (Actual)

July 10, 2020

Last Update Submitted That Met QC Criteria

July 8, 2020

Last Verified

July 1, 2020

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress Disorders, Post-Traumatic

Clinical Trials on rTMS 1Hz

3
Subscribe